NDC 59883-102-01 - ATRIDOX
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59883-102
- Requested NDC
- 59883-102-01
- Package NDCs from labels
- 59883-102-01
- Manufacturer
- Den-Mat Holdings, LLC
- Effective date
- 2020-08-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ATRIDOX - Den-Mat Holdings, LLC | Den-Mat Holdings, LLC | 2020-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | REMEDYREPACK INC. | 051654c7-8ba6-44f2-842c-72f515e9b32d | 2026-09-15 | Warnings, Adverse reactions | 19XTS3T51U |
| doxycycline hyclate | DOXYCYCLINE HYCLATE | HAWAII REPACK, INC | 88c429a1-351d-432e-b69b-d7a0afca482a | 2026-09-09 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | A-S Medication Solutions | 9ecadbc8-3087-4692-916a-b7f392d8e8da | 2026-09-09 | Warnings, Adverse reactions | 19XTS3T51U |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | REMEDYREPACK INC. | 5fdc01c3-c62f-40cf-8351-91cbcc43d379 | 2026-09-01 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline hyclate | DOXYCYCLINE HYCLATE | REMEDYREPACK INC. | df44c686-de34-487a-8741-a0a12993cab2 | 2026-08-27 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline | DOXYCYCLINE HYCLATE | REMEDYREPACK INC. | 2c29f716-bdb0-437d-92a4-d856b87db976 | 2026-08-26 | Warnings, Adverse reactions | 19XTS3T51U |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | NuCare Pharmaceuticals,Inc. | 0106a3d3-db4d-f6ee-e063-6294a90a25e9 | 2026-08-26 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline | DOXYCYCLINE HYCLATE | Acella Pharmaceuticals, LLC | 3fb9f5ad-90a2-4858-bc34-f800d8b2fa90 | 2026-08-18 | Warnings, Adverse reactions | 19XTS3T51U |
| doxycycline | DOXYCYCLINE | REMEDYREPACK INC. | f0fbf63a-e75c-40cf-b2e9-429deaac899d | 2026-08-10 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline | DOXYCYCLINE | Avenacy Inc. | 429813b4-0223-4d85-a844-b1227ff63b1e | 2026-08-06 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Major Pharmaceuticals | e7c14a8e-c713-4f03-94e8-1ec9ae077d4d | 2026-08-05 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | REMEDYREPACK INC. | 2305ab4a-7d08-41f6-9c39-c9b6835be389 | 2026-08-05 | Warnings, Adverse reactions | 19XTS3T51U |
| doxycycline | DOXYCYCLINE | A-S Medication Solutions | fe8cd3c6-36d6-4d92-bc5c-833cd6f9cb32 | 2026-08-04 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline | DOXYCYCLINE HYCLATE | REMEDYREPACK INC. | db53637e-16ac-41b0-b9d5-553471405d64 | 2026-08-03 | Warnings, Adverse reactions | 19XTS3T51U |
| DOXYCYCLINE | DOXYCYCLINE | Lupin Pharmaceuticals, Inc. | 2946fc05-78e5-4669-85d1-3a3979eceae0 | 2026-08-03 | Warnings, Adverse reactions | 19XTS3T51U |
| doxycycline | DOXYCYCLINE | Preferred Pharmaceuticals Inc. | bcc95094-80ed-4023-b2a6-955a4810bfbe | 2026-07-30 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | PD-Rx Pharmaceuticals, Inc. | cf95b2ca-2cf8-49a8-8e3a-f9b0f5b2072c | 2026-07-29 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | PD-Rx Pharmaceuticals, Inc. | 3af9348c-a98b-4059-a5ef-4229e2b33af0 | 2026-07-20 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | PD-Rx Pharmaceuticals, Inc. | 0994d23a-f9e4-4c33-ba44-a1f4ae4a312c | 2026-07-20 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | PD-Rx Pharmaceuticals, Inc. | 1401d590-0967-4c6b-b52b-a83e9f6df097 | 2026-07-17 | Warnings, Adverse reactions | 19XTS3T51U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.